Advocacy Wealth Management Services’s PTC Therapeutics PTCT Stock Holding History

Advocacy Wealth Management Services’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-175	Closed	-$9K	–	110
2022 Q3	$9K	Hold	175	–	–	﹤0.01%	99
2022 Q2	$7K	Hold	175	–	–	﹤0.01%	106
2022 Q1	$7K	Hold	175	–	–	﹤0.01%	115
2021 Q4	$7K	Hold	175	–	–	﹤0.01%	129
2021 Q3	$7K	Hold	175	–	–	﹤0.01%	128
2021 Q2	$7K	Buy	+175	New	+$7.5K	﹤0.01%	146
2021 Q1	–	Sell	-350	Closed	-$21K	–	147
2020 Q4	$21K	Hold	350	–	–	﹤0.01%	87
2020 Q3	$17K	Hold	350	–	–	﹤0.01%	89
2020 Q2	$18K	Hold	350	–	–	﹤0.01%	89
2020 Q1	$16K	Hold	350	–	–	﹤0.01%	84
2019 Q4	$17K	Hold	350	–	–	﹤0.01%	103
2019 Q3	$12K	Hold	350	–	–	0.01%	118
2019 Q2	$16K	Hold	350	–	–	0.01%	110
2019 Q1	$13K	Hold	350	–	–	0.01%	100
2018 Q4	$12K	Hold	350	–	–	0.01%	110
2018 Q3	$16K	Hold	350	–	–	0.01%	104
2018 Q2	$12K	Hold	350	–	–	0.01%	120
2018 Q1	$9K	Hold	350	–	–	0.01%	153
2017 Q4	$6K	Hold	350	–	–	﹤0.01%	183
2017 Q3	$7K	Hold	350	–	–	﹤0.01%	219
2017 Q2	$6K	Hold	350	–	–	﹤0.01%	219
2017 Q1	$3K	Buy	+350	New	+$4.24K	﹤0.01%	280
2016 Q4	–	Sell	-350	Closed	-$5K	–	367
2016 Q3	$5K	Hold	350	–	–	﹤0.01%	326
2016 Q2	$2K	Hold	350	–	–	﹤0.01%	377
2016 Q1	$2K	Hold	350	–	–	﹤0.01%	462
2015 Q4	$11K	Buy	+350	New	+$10.3K	0.01%	335

Other funds holding PTCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Advocacy Wealth Management Services's PTCT Position: Q4 2022 in Review

Advocacy Wealth Management Services sold out of PTC Therapeutics (PTCT) in Q4 2022, closing a stake of 175 shares — an estimated $9K sold.

Advocacy Wealth Management Services first reported a position in PTCT in Q4 2015 and held it in 26 quarters. The position peaked at $21K in Q4 2020. 202 funds tracked by Wall St. Rank hold PTCT as of Q4 2022.

Advocacy Wealth Management Services reported no remaining PTC Therapeutics position as of Q4 2022 after selling out during the quarter.
Advocacy Wealth Management Services sold 175 PTC Therapeutics shares in Q4 2022, an estimated $9K.
Advocacy Wealth Management Services first reported a position in PTC Therapeutics in Q4 2015 and held it in 26 quarters.
Advocacy Wealth Management Services's PTC Therapeutics position peaked at $21K in Q4 2020.
202 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2022.

Based on Advocacy Wealth Management Services's 13F filing for Q4 2022, filed 27 Jan 2023.